Multikinase inhibitors

MYLAN SM 37.5 MYLAN SM 37.5 Pill - white capsule-shape, 19mm

Pill with imprint MYLAN SM 37.5 MYLAN SM 37.5 is White, Capsule-shape and has been identified as Sunitinib Malate 37.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sunitinib (Sunitinib [ soo-nit-in-ib ])-MYLAN SM 37.5 MYLAN SM 37.5-37.5 mg-White-Capsule-shape

Sunitinib
Generic Name: sunitinib [ soo-nit-in-ib ]
Imprint: MYLAN SM 37.5 MYLAN SM 37.5
Strength: 37.5 mg
Color: White
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-6681
Inactive Ingredients: Silicon dioxide, Croscarmellose sodium, Gelatin, Magnesium stearate, Mannitol, Sodium lauryl sulfate, Titanium dioxide, Ferric oxide yellow, Ammonia, Ferrosoferric oxide, Propylene glycol, Shellac,
Latest News
Related Drugs